1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
CERVICAL CANCER AND CYTOLOGY SCREENING IN NEW ZEALAND
Article first published online: 31 AUG 2005
DOI: 10.1111/j.1471-0528.1978.tb15848.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 85, Issue 12, pages 881–886, December 1978
Additional Information
How to Cite
Green, G. H. (1978), CERVICAL CANCER AND CYTOLOGY SCREENING IN NEW ZEALAND. BJOG: An International Journal of Obstetrics & Gynaecology, 85: 881–886. doi: 10.1111/j.1471-0528.1978.tb15848.x
Publication History
- Issue published online: 31 AUG 2005
- Article first published online: 31 AUG 2005
- Abstract
- References
- Cited By
Summary
Cytology screening, used in New Zealand since 1955 at an intensity comparable to that in Canada generally, has not favourably affected incidence and mortality rates for cervical cancer; these have actually risen significantly in 20 to 34-year-old New Zealand women. Canadian claims that mortality falls are related to intensity of cytological screening are not justifiable, so that the significance of the‘pre-cancers’revealed by cytology and the value ofpopulation screening would seem to be doubtful.